{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T19:06:39Z","timestamp":1787943999751,"version":"build-2784847793"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-65415-6","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T13:44:12Z","timestamp":1764078252000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The E3 ligase tripartite motif 7 drives the progression of non-alcoholic fatty liver disease by targeting DUSP10 degradation in male mice"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5816-8282","authenticated-orcid":false,"given":"Feng-Juan","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Ran","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Xin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Wei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jie","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8623-9068","authenticated-orcid":false,"given":"Rong-Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6558-3671","authenticated-orcid":false,"given":"Qun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"65415_CR1","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1016\/j.cgh.2024.03.006","volume":"22","author":"ZM Younossi","year":"2024","unstructured":"Younossi, Z. M. et al. The global epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among patients with type 2 diabetes. Clin. Gastroenterol. Hepatol. 22, 1999\u20132010 (2024).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"65415_CR2","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.ecl.2023.02.001","volume":"52","author":"C Vespoli","year":"2023","unstructured":"Vespoli, C., Mohamed Iqbal, A., Nasser Kabbany, M. & Radhakrishnan, K. Metabolic-associated fatty liver disease in childhood and adolescence. Endocrinol. Metab. Clin. North Am. 52, 417\u2013430 (2023).","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"65415_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1053\/j.gastro.2023.11.007","volume":"166","author":"AM Allen","year":"2024","unstructured":"Allen, A. M., Pose, E., Reddy, K. R., Russo, M. W. & Kamath, P. S. Nonalcoholic fatty liver disease gets renamed as metabolic dysfunction-associated steatotic liver disease: progress but with challenges. Gastroenterology 166, 229\u2013234 (2024).","journal-title":"Gastroenterology"},{"key":"65415_CR4","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell, E. E., Wong, V. W. & Rinella, M. Non-alcoholic fatty liver disease. Lancet 397, 2212\u20132224 (2021).","journal-title":"Lancet"},{"key":"65415_CR5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1021\/acs.jafc.3c02988","volume":"72","author":"H Ding","year":"2024","unstructured":"Ding, H. et al. Chlorogenic acid attenuates hepatic steatosis by suppressing ZFP30. J. Agric Food Chem. 72, 245\u2013258 (2024).","journal-title":"J. Agric Food Chem."},{"key":"65415_CR6","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","volume":"62","author":"CD Byrne","year":"2015","unstructured":"Byrne, C. D. & Targher, G. NAFLD: a multisystem disease. J. Hepatol. 62, S47\u2013S64 (2015).","journal-title":"J. Hepatol."},{"key":"65415_CR7","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1210\/clinem\/dgac321","volume":"107","author":"KE Chan","year":"2022","unstructured":"Chan, K. E. et al. Global prevalence and clinical characteristics of metabolic-associated fatty liver disease: a meta-analysis and systematic review of 10 739 607 individuals. J. Clin. Endocrinol. Metab. 107, 2691\u20132700 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"65415_CR8","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1038\/s41591-024-02958-z","volume":"30","author":"JV Lazarus","year":"2024","unstructured":"Lazarus, J. V. et al. Opportunities and challenges following approval of resmetirom for MASH liver disease. Nat. Med. 30, 3402\u20133405 (2024).","journal-title":"Nat. Med."},{"key":"65415_CR9","doi-asserted-by":"publisher","first-page":"767314","DOI":"10.3389\/fendo.2021.767314","volume":"12","author":"S Albhaisi","year":"2021","unstructured":"Albhaisi, S. & Noureddin, M. Current and potential therapies targeting inflammation in NASH. Front. Endocrinol. 12, 767314 (2021).","journal-title":"Front. Endocrinol."},{"key":"65415_CR10","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M. & Sanyal, A. J. Mechanisms of NAFLD development and therapeutic strategies. Nat. Med. 24, 908\u2013922 (2018).","journal-title":"Nat. Med."},{"key":"65415_CR11","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1002\/hep.28971","volume":"65","author":"FJ Yan","year":"2017","unstructured":"Yan, F. J. et al. The E3 ligase tripartite motif 8 targets TAK1 to promote insulin resistance and steatohepatitis. Hepatology 65, 1492\u20131511 (2017).","journal-title":"Hepatology"},{"key":"65415_CR12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nrd.2015.3","volume":"15","author":"G Musso","year":"2016","unstructured":"Musso, G., Cassader, M. & Gambino, R. Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies. Nat. Rev. Drug Discov. 15, 249\u2013274 (2016).","journal-title":"Nat. Rev. Drug Discov."},{"key":"65415_CR13","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.tem.2015.09.013","volume":"26","author":"SJ Humphrey","year":"2015","unstructured":"Humphrey, S. J., James, D. E. & Mann, M. Protein phosphorylation: a major switch mechanism for metabolic regulation. Trends Endocrinol. Metab. 26, 676\u2013687 (2015).","journal-title":"Trends Endocrinol. Metab."},{"key":"65415_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.immuni.2016.06.020","volume":"45","author":"J Liu","year":"2016","unstructured":"Liu, J., Qian, C. & Cao, X. Post-translational modification control of innate immunity. Immunity 45, 15\u201330 (2016).","journal-title":"Immunity"},{"key":"65415_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01262-x","volume":"19","author":"T Sun","year":"2020","unstructured":"Sun, T., Liu, Z. & Yang, Q. The role of ubiquitination and deubiquitination in cancer metabolism. Mol. Cancer 19, 146 (2020).","journal-title":"Mol. Cancer"},{"key":"65415_CR16","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.tcb.2023.09.001","volume":"34","author":"M Loix","year":"2024","unstructured":"Loix, M., Zelcer, N., Bogie, J. F. J. & Hendriks, J. J. A. The ubiquitous role of ubiquitination in lipid metabolism. Trends Cell Biol. 34, 416\u2013429 (2024).","journal-title":"Trends Cell Biol."},{"key":"65415_CR17","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1038\/nm.3739","volume":"20","author":"D Popovic","year":"2024","unstructured":"Popovic, D., Vucic, D. & Dikic, I. Ubiquitination in disease pathogenesis and treatment. Nat. Med. 20, 1242\u20131253 (2024).","journal-title":"Nat. Med."},{"key":"65415_CR18","doi-asserted-by":"publisher","first-page":"100772","DOI":"10.1016\/j.jbc.2021.100772","volume":"296","author":"CJ Mu\u00f1oz Sosa","year":"2021","unstructured":"Mu\u00f1oz Sosa, C. J., Issoglio, F. M. & Carrizo, M. E. Crystal structure and mutational analysis of the human TRIM7 B30.2 domain provide insights into the molecular basis of its binding to glycogenin-1. J. Biol. Chem. 296, 100772 (2021).","journal-title":"J. Biol. Chem."},{"key":"65415_CR19","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.metabol.2018.02.005","volume":"83","author":"M Montori-Grau","year":"2018","unstructured":"Montori-Grau, M. et al. GNIP1 E3 ubiquitin ligase is a novel player in regulating glycogen metabolism in skeletal muscle. Metabolism 83, 177\u2013187 (2018).","journal-title":"Metabolism"},{"key":"65415_CR20","doi-asserted-by":"publisher","first-page":"19331","DOI":"10.1074\/jbc.M201190200","volume":"277","author":"AV Skurat","year":"2002","unstructured":"Skurat, A. V., Dietrich, A. D., Zhai, L. & Roach, P. J. GNIP, a novel protein that binds and activates glycogenin, the self-glucosylating initiator of glycogen biosynthesis. J. Biol. Chem. 277, 19331\u201319338 (2002).","journal-title":"J. Biol. Chem."},{"key":"65415_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7782","volume":"6","author":"A Chakraborty","year":"2015","unstructured":"Chakraborty, A., Diefenbacher, M. E., Mylona, A., Kassel, O. & Behrens, A. The E3 ubiquitin ligase Trim7 mediates c-Jun\/AP-1 activation by Ras signalling. Nat. Commun. 6, 6782 (2015).","journal-title":"Nat. Commun."},{"key":"65415_CR22","doi-asserted-by":"publisher","first-page":"109543","DOI":"10.1016\/j.cellsig.2020.109543","volume":"69","author":"J Jin","year":"2020","unstructured":"Jin, J. et al. E3 ubiquitin ligase TRIM7 negatively regulates NF-kappa B signaling pathway by degrading p65 in lung cancer. Cell Signal 69, 109543 (2020).","journal-title":"Cell Signal"},{"key":"65415_CR23","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41586-020-2457-8","volume":"585","author":"MI Giraldo","year":"2020","unstructured":"Giraldo, M. I. et al. Envelope protein ubiquitination drives entry and pathogenesis of Zika virus. Nature 585, 414\u2013419 (2020).","journal-title":"Nature"},{"key":"65415_CR24","doi-asserted-by":"publisher","first-page":"102955","DOI":"10.1016\/j.ebiom.2020.102955","volume":"59","author":"C Zhou","year":"2020","unstructured":"Zhou, C. et al. N6-Methyladenosine modification of the TRIM7 positively regulates tumorigenesis and chemoresistance in osteosarcoma through ubiquitination of BRMS1. EBioMedicine 59, 102955 (2020).","journal-title":"EBioMedicine"},{"key":"65415_CR25","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.molimm.2019.01.015","volume":"109","author":"M Lu","year":"2019","unstructured":"Lu, M. et al. E3 ubiquitin ligase tripartite motif 7 positively regulates the TLR4-mediated immune response via its E3 ligase domain in macrophages. Mol. Immunol. 109, 126\u2013133 (2019).","journal-title":"Mol. Immunol."},{"key":"65415_CR26","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1038\/s41418-019-0464-9","volume":"27","author":"L Zhu","year":"2020","unstructured":"Zhu, L. et al. The E3 ubiquitin ligase TRIM7 suppressed hepatocellular carcinoma progression by directly targeting Src protein. Cell Death Differ. 27, 1819\u20131831 (2020).","journal-title":"Cell Death Differ."},{"key":"65415_CR27","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.bbrc.2019.02.001","volume":"511","author":"X Hu","year":"2019","unstructured":"Hu, X. et al. Tripartite motif-containing protein 7 regulates hepatocellular carcinoma cell proliferation via the DUSP6\/p38 pathway. Biochem. Biophys. Res Commun. 511, 889\u2013895 (2019).","journal-title":"Biochem. Biophys. Res Commun."},{"key":"65415_CR28","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s10555-008-9123-1","volume":"27","author":"SM Keyse","year":"2008","unstructured":"Keyse, S. M. Dual-specificity MAP kinase phosphatases (MKPs) and cancer. Cancer Metastasis Rev. 27, 253\u2013261 (2008).","journal-title":"Cancer Metastasis Rev."},{"key":"65415_CR29","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.3390\/ijms20071626","volume":"20","author":"M Jim\u00e9nez-Mart\u00ednez","year":"2019","unstructured":"Jim\u00e9nez-Mart\u00ednez, M., Stamatakis, K. & Fresno, M. The Dual-Specificity Phosphatase 10 (DUSP10): its role in cancer, inflammation, and immunity. Int. J. Mol. Sci. 20, 1626 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"65415_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072340","volume":"8","author":"HR Choi","year":"2013","unstructured":"Choi, H. R. et al. Dual-specificity phosphatase 10 controls brown adipocyte differentiation by modulating the phosphorylation of p38 mitogen-activated protein kinase. PLoS One 8, e72340 (2013).","journal-title":"PLoS One"},{"key":"65415_CR31","doi-asserted-by":"publisher","first-page":"14875","DOI":"10.1074\/jbc.M115.660969","volume":"290","author":"Y Zhang","year":"2015","unstructured":"Zhang, Y. et al. Regulation of adipose tissue inflammation and insulin resistance by MAPK phosphatase 5. J. Biol. Chem. 290, 14875\u201314883 (2015).","journal-title":"J. Biol. Chem."},{"key":"65415_CR32","doi-asserted-by":"publisher","first-page":"3410","DOI":"10.1016\/j.cell.2021.04.047","volume":"184","author":"W Fan","year":"2021","unstructured":"Fan, W. et al. TRIM7 inhibits enterovirus replication and promotes emergence of a viral variant with increased pathogenicity. Cell 184, 3410\u20133425.e17 (2021).","journal-title":"Cell"},{"key":"65415_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008387","volume":"16","author":"B Yang","year":"2020","unstructured":"Yang, B. et al. RNF90 negatively regulates cellular antiviral responses by targeting MITA for degradation. PLoS Pathog. 16, e1008387 (2020).","journal-title":"PLoS Pathog."},{"key":"65415_CR34","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.1074\/jbc.M208359200","volume":"278","author":"YH Lee","year":"2003","unstructured":"Lee, Y. H., Giraud, J., Davis, R. J. & White, M. F. c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade. J. Biol. Chem. 278, 2896\u20132902 (2003).","journal-title":"J. Biol. Chem."},{"key":"65415_CR35","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1042\/BCJ20190799","volume":"477","author":"FJ Yan","year":"2020","unstructured":"Yan, F. J. et al. C-Jun\/C7ORF41\/NF-\u03baB axis mediates hepatic inflammation and lipid accumulation in NAFLD. Biochem J. 477, 691\u2013708 (2020).","journal-title":"Biochem J."},{"key":"65415_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28641-w","volume":"13","author":"M Xu","year":"2022","unstructured":"Xu, M. et al. The E3 ubiquitin-protein ligase Trim31 alleviates non-alcoholic fatty liver disease by targeting Rhbdf2 in mouse hepatocytes. Nat. Commun. 13, 1052 (2022).","journal-title":"Nat. Commun."},{"key":"65415_CR37","doi-asserted-by":"publisher","first-page":"6981","DOI":"10.1038\/sj.onc.1203185","volume":"18","author":"A Theodosiou","year":"1999","unstructured":"Theodosiou, A. et al. MKP5, a new member of the MAP kinase phosphatase family, which selectively dephosphorylates stress-activated kinases. Oncogene 18, 6981\u20136988 (1999).","journal-title":"Oncogene"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65415-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65415-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65415-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T13:44:12Z","timestamp":1764078252000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65415-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["65415"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-65415-6","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"25 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10437"}}